These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1474431)

  • 21. A study of the capability of manufacturers of generic hormonal contraceptives in lower- and middle-income countries.
    Hall PE; Oehler J; Woo P; Zardo H; Chinery L; Singh JS; Jooseery SH; Essah NM
    Contraception; 2007 Apr; 75(4):311-7. PubMed ID: 17362712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What have been the strategies for the registration, positioning and control of medical information for intramuscular artemether?
    Helenport JP; Roche G
    Med Trop (Mars); 1998; 58(3 Suppl):73-6. PubMed ID: 10212906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality control of drugs. Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce. Participating countries--supplementary list 4.
    WHO Chron; 1984; 38(3):116-24. PubMed ID: 6485308
    [No Abstract]   [Full Text] [Related]  

  • 24. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2004; 926():1-109. PubMed ID: 15918537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality control of drugs. Certification scheme on the quality of pharmaceutical products moving in international commerce. Participating countries--supplementary list 3.
    WHO Chron; 1982; 36(3):107-13. PubMed ID: 7123920
    [No Abstract]   [Full Text] [Related]  

  • 26. European Pharmacopoeia (EP), USDA and MAFF standards--will they ever be harmonised under the VICH umbrella?
    Castle P
    Dev Biol (Basel); 2005; 121():227-34. PubMed ID: 15962485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Certification of suitability of monographs of the European pharmacopoeia].
    Artiges A
    Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2003; 908():i-viii, 1-136, back cover. PubMed ID: 12768889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The World Health Organization's role and future plans in laboratory standardization.
    Heuck CC
    Scand J Clin Lab Invest Suppl; 1993; 212():3-7. PubMed ID: 8465149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirements for anti-tuberculosis drug tender requests.
    Trébucq A; Caudron JM; Pinel J
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S358-61; discussion S381-7. PubMed ID: 10593718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The harmonization of the regulation of blood products: a European perspective.
    Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
    Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacopoeia as a pharmaceutical code for public health authorities.
    Marini-Bettolo GB
    Ann Ist Super Sanita; 1975; 11(3-4):254-68. PubMed ID: 1234727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.